About Galactoside alpha-(1,2)-fucosyltransferase 1
Galactoside alpha-(1,2)-fucosyltransferase 1 (FUT1) is a protein
from Homo sapiens identified by UniProt accession
P19526, 365 residues long.
MolForge cross-references it against 0 known binders and
537 disease associations.
Target properties
| Protein name | Galactoside alpha-(1,2)-fucosyltransferase 1 |
| UniProt accession | P19526 |
| Gene | FUT1 |
| Organism | Homo sapiens |
| Length | 365 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (537)
Diseases linked to this target (Open Targets).
- alkaline phosphatase measurement · score 0.29
- urinary albumin to creatinine ratio · score 0.28
- albuminuria · score 0.27
- bombay phenotype · score 0.24
- sodium measurement · score 0.24
- low density lipoprotein cholesterol measurement · score 0.23
- apolipoprotein B measurement · score 0.22
- total cholesterol measurement · score 0.22
- serum non-albumin protein measurement · score 0.22
- neurodegenerative disease · score 0.17
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P19526-F1 | alphafold | PREDICTED | 87.90 | — |
Amino-acid sequence (365 residues)
MWLRSHRQLC LAFLLVCVLS VIFFLHIHQD SFPHGLGLSI LCPDRRLVTP PVAIFCLPGT AMGPNASSSC PQHPASLSGT WTVYPNGRFG NQMGQYATLL ALAQLNGRRA FILPAMHAAL APVFRITLPV LAPEVDSRTP WRELQLHDWM SEEYADLRDP FLKLSGFPCS WTFFHHLREQ IRREFTLHDH LREEAQSVLG QLRLGRTGDR PRTFVGVHVR RGDYLQVMPQ RWKGVVGDSA YLRQAMDWFR ARHEAPVFVV TSNGMEWCKE NIDTSQGDVT FAGDGQEATP WKDFALLTQC NHTIMTIGTF GFWAAYLAGG DTVYLANFTL PDSEFLKIFK PEAAFLPEWV GINADLSPLW TLAKP
Explore Galactoside alpha-(1,2)-fucosyltransferase 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets